Abstracts

Submissions are open!

Some organizations’ email security can block automated messages (e.g., confirmations). To ensure you receive our emails, please add noreply@theisn.org, registrationswcn@theisn.org, abstractswcn@theisn.org and facultywcn@theisn.org (as well as the theisn.org domain) to your safe-sender/allowlist. You may need your IT team’s assistance.

Share your research with a global audience and contribute to advancing kidney care worldwide. Abstract presentations are the heart of the World Congress of Nephrology—previous editions have featured over 1,500 poster sessions on average. Be part of this vibrant exchange of knowledge and innovation.

Posters can be viewed throughout the day in the Exhibition Hall (check opening hours). E-posters are also available on the WCN portal and onsite at the Conference Center, 3F.

Moderated poster sessions will take place on March 28 (5:30–6:30 p.m.) and March 29–30 (5 –6 p.m.), offering a great opportunity to engage directly with presenting authors and discuss emerging research.

View the poster presentation schedule by category or author name.

You can also browse WCN’26 abstracts and late-breaking clinical trials abstracts in the Kidney International Reports® supplement and explore visual abstracts of selected award-winning research, prepared by the WCN Social Media team.

Abstract categories and topics

Abstract instructions and requirements

Abstract submission conditions

Abstract awards

Submit your abstract

Important dates

Submission opens

June 22, 2026

Submission deadline

October 28, 2026

Notification of acceptance

December 8, 2026

Abstract categories and topics

Better Kidney Health For All: Addressing public health challenges, epidemiology, and innovative approaches to improve kidney care globally

  1. Preventive science
  2. Environmental health & kidneys
  3. Population health science
  4. Global kidney health
  5. Policy/advocacy
  6. AKI prevention
  7. CKD prevention

Preserving Health in Kidney Disease: Exploring the mechanisms, progression, and management of acute and chronic kidney disease, dialysis, and transplantation

  1. Dialysis
  2. Chronic kidney disease – mineral and bone disorder
  3. Anemia
  4. Interventional nephrology
  5. Rare kidney disease
  6. Transplantation & transplantation access
  7. ADPKD & Alports kidney disease
  8. Exercise in CKD

Environmentally Sustainable Kidney Care: Research and initiatives that advance environmentally responsible, ethically sound, and financially sustainable approaches to kidney care.

  1. Environment
  2. Ethics
  3. Financial

Clinical Trials in Flight: Clinical trials that are active and currently underway but not yet complete

Note: A placeholder abstract must be submitted by October 28, 2026, to submit in this category. Final data must be submitted by January 13, 2027
(Read the specific conditions that apply to this category)

The Smart Kidney: Advancing research in glomerular diseases, genetics, and cutting-edge nephrology technologies

  1. AI
  2. Machine learning
  3. Precision medicine
  4. Complement medicine
  5. Genetics
  6. Basic science (Omics)
  7. Large datasets
  8. Glomerular diseases (GN)

The Interconnected Kidney: Investigating the kidney’s role in systemic conditions, pregnancy, cancer, and vascular health

  1. Cardio-kidney metabolic syndrome
  2. Cardiovascular disease
  3. Hypertension
  4. Brain-kidney axis
  5. Pulmonary-kidney syndrome
  6. Multimorbidity
  7. Onconephrology
  8. Gut-kidney axis
  9. Kidney liver connect

Education: Enhancing nephrology training, curriculum development, and digital learning opportunities

  1. Training
  2. Social Media
  3. Curriculum
  4. Online Learning

Late-Breaking Clinical Trials: Showcasing groundbreaking research and newly emerging data shaping the future of kidney care

Note: A placeholder abstract must be submitted by October 28, 2026, to qualify for late-breaking submission. Final data must be submitted by January 13, 2027.
(Read the specific conditions that apply to this category)

Preserving Kidney Health: Exploring the mechanisms, progression, and management of acute and chronic kidney disease, dialysis, and transplantation

  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum
  • Acute Kidney Injury – Mechanisms, Experimental Models and Biomarkers
  • Acid-base and Electrolyte Abnormalities in Kidney Disease
  • Other AKI
  • Chronic Kidney Disease Diagnosis, Classification and Progression
  • Chronic Kidney Disease Complications
  • Diabetic Kidney Disease, Drugs and Treatments
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine
  • Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
  • Urologic Disorders – Stones, Nephrocalcinosis
  • Other CKD
  • Haemodialysis, Haemodiafiltration and Vascular Access
  • Kidney Transplantation and Transplant Immunology
  • Peritoneal Dialysis

Better Kidney Health: Addressing public health challenges, epidemiology, and innovative approaches to improve kidney care globally

  • Tropical Kidney Diseases
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications
  • Special Challenges in the Burden and Management of CKD in Developing Countries
  • Bioethics, Supportive/Palliative Care and Quality of Life in Kidney Failure
  • Other KF (Kidney Failure)
  • Artificial Intelligence and Machine Learning
  • Covid-19 and The Kidney

The Smart Kidney: Advancing research in glomerular diseases, genetics, and cutting-edge nephrology technologies

  • Experimental Models – Glomerulonephritis
  • Clinical Glomerulonephritis
  • Physiology of Tubular Function and Tubulointerstitial Kidney Disease, Renal Model Systems (Organoids and Kidney on a Chip)
  • Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
  • Nephrotic Syndrome

The Interconnected Kidney: Investigating the kidney’s role in systemic conditions, pregnancy, cancer, and vascular health

  • Kidney in Pregnancy and Post-Partum
  • Cancer Therapy and Kidney Disease
  • Renal and Electrolyte Manifestation of Onconephrology
  • Vascular Biology and Endothelial Function
  • Essential Hypertension and Renovascular Kidney Disease
  • Epidemiology, Outcomes and Health Services Research in Dialysis

Education: Enhancing nephrology training, curriculum development, and digital learning opportunities

  • Training
  • Social Media
  • Curriculum
  • Online Learning

Late Breaking Clinical Trials: Showcasing groundbreaking research and newly emerging data shaping the future of kidney care

Note: A placeholder abstract must be submitted by October 22, 2025, to qualify for late-breaking submission.

(Read the specific conditions that apply to this category)

Abstract instructions and requirements

  • Language: English
  • Character limit: Up to 3,400 characters, including spaces. This excludes authors’ names, affiliations, keywords, and any tables or graphs inserted as images.
  • Structure: Use a structured format with introduction, methods, results, and conclusion sections. Review carefully for typos, misspellings, and errors before submission.
  • Co-authors: You may list up to 15 co-authors per abstract.
  • Images: Images must be in JPEG or PNG format (maximum 640wx480h pixels, 1.5 MB).
  • Case reports that present novel hypotheses, pathologies, treatments, or ethical issues are welcome. However, they are only likely to be selected if the originality is highlighted effectively.
  • Encore abstracts: Allowed if permitted by both the initial and subsequent conferences. Authors must disclose this at the end of the abstract: “This abstract was also submitted for the [insert meeting title] congress.“
  • Ethical compliance: Research must adhere to the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.
    • By submitting, you confirm that your work complies with ethical principles regarding live donation and research on human subjects.
  • Embargo policy: For abstracts accepted for presentation and publication during WCN’27, the embargo policy applies according to your selection during the submission process.
    • Published prior to the congress
    • Published after the embargo is lifted on April 4, 2027 at 12 p.m. MYT.
    • Or, to NOT published

Details about AI technologies usage:

  • Generative AI disclosure: If generative AI or AI-assisted technologies were used in the writing process, authors must disclose this during submission and include a statement at the end of the abstract under the heading Declaration of Generative AI and AI-Assisted Technologies in the Writing Process.
  • Permitted use of AI: Generative AI and AI-assisted technologies may only be used to improve readability and language. Authors must maintain human oversight and carefully review and edit all content, as AI-generated outputs may be inaccurate, incomplete, or biased.
  • Authorship: AI and AI-assisted technologies must not be listed as authors or co-authors, nor cited as authors. Authorship responsibilities can only be attributed to humans, in accordance with the Kidney International Reports® (Elsevier) policy for authors.
  • No disclosure required: Disclosure is not required for the use of basic tools solely for grammar, spelling, reference checking, or similar editorial assistance. If there is nothing to disclose, no statement is required.

Abstract submission conditions

  • Accepted abstracts will be published online (for those who give authorization) in Kidney International Reports®. No printed abstract book will be available.
  • Presenting authors must register for the congress by January 13, 2027, to have their abstract published and to present a poster. Failure to register by this date will result in the abstract not being published or presented, and the abstract submission fee will not be refunded. 
    • Presenters must register using the same email used for abstract submission. If they fail to do so and do not communicate the change of email to the Abstract team by 13 January, 2027, the abstract might not be published in Kidney International Reports® or presented onsite. WCN organizers will not be held responsible for non-publication, and no refund will be issued. 
    • ISN members from low- and lower-middle-income countries may benefit from travel grants that cover complimentary registration to WCN’27 and a fixed monetary contribution toward travel and accommodation. Find out if you qualify.
  • If the presenting author is unable to attend, a co-author may present the abstract instead, provided they are registered.
    • The original presenter must inform the Abstract team (abstractswcn@theisn.org) of the change by January 13, 2027 and provide the registration number of the new presenting author at the same time. Failure to do so will result in abstract withdrawal. No exceptions.
  • Abstract handling fee is 50 USD per abstract, non-refundable.
    • Fee waivers apply to submitters from low-income countries (as per World Bank income classifications)
    • Payment must be made via credit card (American Express, MasterCard, or Visa). Bank transfers are not accepted.
    • No refunds will be issued if you choose to withdraw your abstract. 
    • If you wish to make changes to your abstract before the submission deadline, please contact the Abstracts Team rather than creating a new submission. Any duplicate abstract created for this purpose will be withdrawn, and no refund will be provided. 
    • If you have multiple invoices associated with your WCN account, please carefully select only the invoices you intend to pay on the “Confirm & Pay” page. Payments made for abstracts that you did not intend to submit are non-refundable.
  • Once submitted, abstracts cannot be edited or withdrawn.
  • All copyrights are assigned to the International Society of Nephrology (ISN).
  • All submitted abstracts will be considered for poster presentations.

Late-Breaking Clinical Trials Abstracts showcase groundbreaking data and major scientific advancements that became available after the regular abstract submission deadline.

Clinical Trials in Flight feature ongoing clinical studies that are currently underway, or processing data as a preview of upcoming research and future of the field.

The Scientific Program Working Group will review these abstracts for potential presentation at WCN’27.

Key considerations

  • These abstracts highlight novel, practice-changing studies, including the latest trial data and research findings.
  • This is not an extension of the general submission deadline.
  • A placeholder abstract must be submitted during the regular submission period (deadline: October 28, 2026).

Conditions

  • Accepted abstracts will be published online in Kidney International Reports® upon author confirmation / authorization. No printed abstract book will be available.
  • Selected abstracts may be invited for oral presentation at WCN’27.
  • Presenting authors must register for the congress by January 13, 2027, to have their abstract published and to present a poster. Failure to register by this date will result in the abstract not being published or presented.
    • Presenters must register using the same email used for abstract submission. If they fail to do so and do not communicate the change of email to the Abstract team by 13 January, 2027, the abstract might not be published in Kidney International Reports® or presented onsite. WCN organizers will not be held responsible for non-publication.
    • ISN members from low- and lower-middle-income countries may benefit from travel grants that cover complimentary registration to WCN’27 and a fixed monetary contribution toward travel and accommodation. Find out if you qualify.
  • If the presenting author is unable to attend, a co-author may present the abstract instead, provided they are registered.
    • The original presenter must inform the Abstract team (abstractswcn@theisn.org) of the change by January 13, 2027 and provide the registration number of the new presenting author at the same time. Failure to do so will result in abstract withdrawal. No exceptions.
  • Only abstracts with a placeholder submission by October 28, 2026, will be considered.
  • Abstract handling fee is 100 USD per abstract, non-refundable. The fee is not waived for low-income country applicants.
  • All copyrights are assigned to the International Society of Nephrology (ISN).
  • To submit a late-breaking clinical trials abstracts: log in to your congress profile, go to Abstracts > Submit New Abstract > Select “Late-breaking Abstract Submission”.

Post-submission updates

  • The submission portal will temporarily reopen until January 13, 2027, for authors to make final modifications.
Submit your abstract

Abstract submission confirmation and notification of acceptance

After submitting your abstract, you will receive a confirmation email within two business days. If you do not see the email, please check your spam folder.

For submissions made on the final deadline (October 28, 2026), if you do not receive confirmation within 48 hours, contact abstractswcn@theisn.org to ensure your submission was received.

Authors of accepted abstracts will be notified via email by December 8, 2026.

Abstract awards

Discover the awards that will be celebrated at WCN’27 and learn how your work could be recognized on the global stage.

Best Abstract Awards

Awarded to the top three abstracts selected by the Abstract committee

Prize:

  • One year of complimentary ISN membership for 2027. If the winner already has a current ISN membership for 2027, alternative options will be offered
  • Award certificate
  • Recognition on the WCN’27 website, app, and ISN social media channels

ISN Grants Best Abstract Awards

Awarded to the best three abstracts submitted by participants in the ISN Fellowship, Clinical Research and Mentorship programs (three awards per program)

Eligibility:

  • Abstract authors must have participated in the ISN Fellowship, Clinical Research or Mentorship program within the past five years
  • Submitted abstract must be related to their activities in that program

Prize:

  • Complimentary registration for WCN’27
  • Monetary prize for each program’s winners (more information to come)
  • Presentation of the abstract at the Grants Awards session at WCN’27
  • Award certificate
  • Recognition on the WCN’27 website, app, and ISN social media channels 

Young Nephrologists Best Abstract Awards
Two awards will be given for the Best Basic Science Abstract and Best Clinical Research abstract, selected by the ISN Young Nephrologists Committee

Eligibility: Abstract authors must be under 40 years old

Prize:

  • Complimentary registration for WCN’27
  • Up to $3,500 USD for travel and accommodation to attend WCN’27
  • Presentation of the abstract at the Young Nephrologists Committee session, part of the WCN’27 scientific program